[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 6, Issue 3 (Int J Mol Cell Med (In press) 2017) ::
Int J Mol Cell Med 2017, 6(3): 0-0 Back to browse issues page
Neuroinflammation in Autism Spectrum Disorders: the Role of High Mobility Group Box 1 Protein
Valeria Dipasquale *1, Maria Concetta Cutrupi 2, Laura Colavita 3, Sara Manti 2, Caterina Cuppari 2, Carmelo Salpietro 2
1- Department of Adult and Childhood Human Pathology, Unit of Pediatrics, University Hospital of Messina, Messina, Italy., Department of Adult and Childhood Human Pathology, Unit of Pediatrics, University Hospital of Messina, Messina, Italy. , dipasquale.valeria@libero.it
2- Department of Adult and Childhood Human Pathology, Unit of Pediatrics, University Hospital of Messina, Messina, Italy., Department of Adult and Childhood Human Pathology, Unit of Pediatrics, University Hospital of Messina, Messina, Italy.
3- Department of Pediatrics, Hospital Umberto I° of Siracusa, Siracusa, Italy., Department of Pediatrics, Hospital Umberto I° of Siracusa, Siracusa, Italy.
Abstract:   (575 Views)

The pathogenesis of autism spectrum disorder (ASD) likely involves genetic and environmental factors, impacting the complex neurodevelopmental and behavioral abnormalities of the disorder. Scientific researches emerging within the past two decades suggest that immune dysfunction and inflammation have pathogenic influences through different mechanisms, all leading to both a chronic state of low grade inflammation and alterations in the central nervous system and immune response, respectively. The high mobility group box-1 protein (HMGB1) is an inflammatory marker which has been shown to play a role in inducing and influencing neuroinflammation. Current evidences suggest a possible role in the multiple pathogenic mechanisms of ASD. The aim of this manuscript is to review the major hypothesis for ASD pathogenesis, with specific regards to the immunological ones, and to provide a comprehensive review of the current data about the association between HMGB1 and ASD. A systematic search has been carried out through Medline via Pubmed to identify all original articles published in English, on the basis of the following keywords: “HMGB1”, “autism”, “autism spectrum disorder”, “neuroinflammation”, and “child”.

Keywords: autism spectrum disorder/high mobility group box-1/marker/neuroinflammation/immunity
Full-Text [PDF 210 kb]   (124 Downloads)    
Type of Study: Mini-review | Subject: Molecular & Cellular Immunology
Received: 2017/07/8 | Accepted: 2017/09/6 | Published: 2017/09/26
Send email to the article author

Add your comments about this article
Your username or Email:

Write the security code in the box >



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Dipasquale V, Cutrupi M C, Colavita L, Manti S, Cuppari C, Salpietro C. Neuroinflammation in Autism Spectrum Disorders: the Role of High Mobility Group Box 1 Protein. Int J Mol Cell Med. 2017; 6 (3)
URL: http://ijmcmed.org/article-1-711-en.html
Volume 6, Issue 3 (Int J Mol Cell Med (In press) 2017) Back to browse issues page
International Journal of Molecular and Cellular Medicine (IJMCM) International Journal of Molecular and Cellular Medicine (IJMCM)
Persian site map - English site map - Created in 0.045 seconds with 801 queries by yektaweb 3531